A Clinical Trial to Assess the Safety and Immunogenicity of New Malaria Vaccine Candidates ChAd63 Pfs25-IMX313 and MVA Pfs25-IMX313
Clinical trial NCT02532049 · COMPLETED
Trial details
- NCT number
- NCT02532049
- Sponsor
- University of Oxford
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-12
- Primary completion
- 2017-05-25
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.